Keyphrases
Atrial Fibrillation
100%
Arrhythmia
38%
Dofetilide
34%
Antiarrhythmic Drugs
33%
Amiodarone
31%
Clinical Trials
28%
Congestive Heart Failure
28%
Atrial Flutter
21%
Sinus Rhythm
21%
Ventricular Arrhythmia
21%
Rate Control
19%
Proarrhythmia
19%
Torsades Des Pointes
16%
Ventricular Tachycardia
16%
Implantable Defibrillator
16%
Biventricular Pacing
15%
Cardiac Autonomic Function
15%
Spontaneous Transformation
14%
Post-myocardial Infarction
14%
Dronedarone
14%
Supraventricular Tachycardia
13%
Meta-analysis
13%
Heart Rate Variability
12%
Sudden Cardiac Death
12%
Pharmacological Therapy
11%
During Pregnancy
11%
High Risk
11%
QT-prolonging Drugs
10%
Catheter Ablation
10%
Circadian Pattern
10%
Confidence Interval
9%
Acute Treatment
9%
Biventricular Pacemaker
9%
Cardiac Resynchronization Therapy
9%
All-cause Mortality
9%
Middle-aged
9%
Heart Failure
9%
Risk Factors
9%
Patients with Heart Failure
8%
Gender Differences
8%
Atrioventricular
8%
New-onset Atrial Fibrillation
8%
Conversion Rate
8%
Beta-blockers
7%
Structural Heart Disease
7%
Antiarrhythmic Agents
7%
Implantable Cardioverter-defibrillator Therapy
7%
Clinical High Risk
7%
Pharmacology
7%
Sodium Channel
7%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
93%
Antiarrhythmic Agent
44%
Dofetilide
35%
Heart Arrhythmia
34%
Clinical Trial
34%
Amiodarone
28%
Congestive Heart Failure
24%
Heart Atrium Flutter
22%
Dronedarone
21%
Heart Ventricle Tachycardia
20%
Torsade Des Pointes
20%
Heart Failure
16%
Vernakalant
14%
Sudden Cardiac Death
13%
Heart Proarrhythmia
12%
Recurrent Disease
12%
Adverse Event
9%
All Cause Mortality
9%
Heart Ventricle Fibrillation
9%
Infarction
8%
New-Onset Atrial Fibrillation
8%
Heart Infarction
8%
Heart Ventricle Arrhythmia
7%
Supraventricular Tachycardia
7%
Congenital Heart Disease
7%
Sotalol
7%
Heart Disease
7%
Antiarrhythmic Drug
7%
QT Prolongation
7%
Sodium Channel
7%
Antivitamin K
7%
Brugada Syndrome
6%
Blocking Agent
6%
Apixaban
6%
Ischemic Heart Disease
6%
Atherosclerosis
6%
Drug Development
6%
Direct Oral Anticoagulant
6%
Metabolic Syndrome X
6%
Potassium Channel
5%
Paroxysmal Atrial Fibrillation
5%
Medicine and Dentistry
Atrial Fibrillation
40%
Ventricular Tachycardia
22%
Congestive Heart Failure
17%
Cardiac Resynchronization Therapy
15%
Meta-Analysis
12%
Health Care Cost
12%
New-Onset Atrial Fibrillation
12%
Tachyarrhythmia
12%
Implantable Automatic Defibrillator
10%
Supraventricular Tachycardia
9%
Cardioversion
9%
Cardiac Dysrhythmia
8%
Anticoagulation
7%
Electrocardiogram
7%
Clinical Trial
7%
Antiarrhythmic Agent
7%
Vitamin K Antagonist
7%
Defibrillator
7%
Heart Failure
7%
Dofetilide
6%
Apixaban
6%
False Positive Result
6%
Transesophageal Echocardiography
6%
Patient Selection
6%
Direct Oral Anticoagulant
6%
Heart Valve Bioprosthesis
6%
Vernakalant
6%
Systematic Review
6%
Ablation
6%
Tricuspid Insufficiency
6%
Infarction
6%
Great Cardiac Vein
6%
Hypertrophic Obstructive Cardiomyopathy
6%
Clinical Significance
6%
Thromboembolism
5%